Pliant Therapeutics Stock Market Value
| PLRX Stock | USD 13.46 0.48 3.70% |
| Symbol | Pliant |
Pliant Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pliant Therapeutics. If investors know Pliant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pliant Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.35) | Quarterly Revenue Growth (1.00) | Return On Assets (0.28) | Return On Equity (0.48) |
The market value of Pliant Therapeutics is measured differently than its book value, which is the value of Pliant that is recorded on the company's balance sheet. Investors also form their own opinion of Pliant Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Pliant Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pliant Therapeutics' market value can be influenced by many factors that don't directly affect Pliant Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pliant Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pliant Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pliant Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Pliant Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pliant Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pliant Therapeutics.
| 10/26/2024 |
| 11/25/2024 |
If you would invest 0.00 in Pliant Therapeutics on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding Pliant Therapeutics or generate 0.0% return on investment in Pliant Therapeutics over 30 days. Pliant Therapeutics is related to or competes with Eliem Therapeutics, HCW Biologics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel the... More
Pliant Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pliant Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pliant Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.35 | |||
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 24.35 | |||
| Value At Risk | (5.55) | |||
| Potential Upside | 5.37 |
Pliant Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pliant Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pliant Therapeutics' standard deviation. In reality, there are many statistical measures that can use Pliant Therapeutics historical prices to predict the future Pliant Therapeutics' volatility.| Risk Adjusted Performance | 0.0168 | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.57) | |||
| Sortino Ratio | (0.03) | |||
| Treynor Ratio | 0.0158 |
Pliant Therapeutics Backtested Returns
At this stage we consider Pliant Stock to be not too volatile. Pliant Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.0291, which implies the firm had a 0.0291% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Pliant Therapeutics, which you can use to evaluate the volatility of the company. Please check Pliant Therapeutics' Coefficient Of Variation of 8675.22, risk adjusted performance of 0.0168, and Semi Deviation of 3.19 to confirm if the risk estimate we provide is consistent with the expected return of 0.11%. Pliant Therapeutics has a performance score of 2 on a scale of 0 to 100. The company holds a Beta of 2.15, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Pliant Therapeutics will likely underperform. Pliant Therapeutics right now holds a risk of 3.88%. Please check Pliant Therapeutics treynor ratio, as well as the relationship between the expected short fall and day median price , to decide if Pliant Therapeutics will be following its historical price patterns.
Auto-correlation | -0.07 |
Very weak reverse predictability
Pliant Therapeutics has very weak reverse predictability. Overlapping area represents the amount of predictability between Pliant Therapeutics time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pliant Therapeutics price movement. The serial correlation of -0.07 indicates that barely 7.0% of current Pliant Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.07 | |
| Spearman Rank Test | -0.46 | |
| Residual Average | 0.0 | |
| Price Variance | 0.41 |
Pliant Therapeutics lagged returns against current returns
Autocorrelation, which is Pliant Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pliant Therapeutics' stock expected returns. We can calculate the autocorrelation of Pliant Therapeutics returns to help us make a trade decision. For example, suppose you find that Pliant Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Pliant Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pliant Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pliant Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pliant Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Pliant Therapeutics Lagged Returns
When evaluating Pliant Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pliant Therapeutics stock have on its future price. Pliant Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pliant Therapeutics autocorrelation shows the relationship between Pliant Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Pliant Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Pliant Stock Analysis
When running Pliant Therapeutics' price analysis, check to measure Pliant Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pliant Therapeutics is operating at the current time. Most of Pliant Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pliant Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pliant Therapeutics' price. Additionally, you may evaluate how the addition of Pliant Therapeutics to your portfolios can decrease your overall portfolio volatility.